Research programme: KLH-conjugated vaccines - Stellar BiotechnologiesAlternative Names: Keyhole limpet haemocyanin conjugated vaccine - Stellar; PSII-KLH conjugate
Latest Information Update: 22 Mar 2017
At a glance
- Originator University of Guelph
- Developer Matrivax
- Class Bacterial polysaccharides; Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Clostridium infections